InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The firm operates in multiple industry segments providing in-vitro (non-animal) consumer, product, and environmental safety test method to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. The company sells three proprietary in vitro products: Ocular Irritection used to evaluate the potential for ocular irritation, Irritection Dermal used to evaluate the potential for dermal irritation, and Corrositex used to determine corrosivity level classifications. The company sells its products to independent distributors, contract laboratories, and end users.
Follow-Up Questions
Invitro International (IVRO) の株価収益率はいくらですか？
Invitro International の株価収益率は 281.7533 です。
Invitro International のCEOは誰ですか？
W. Richard Ulmer は Invitro International の President で、1994 から在籍しています。
